In Vitro Fertilization Market

In Vitro Fertilization Market by Product (Imaging System, Incubator, Cabinets, Sperm Separation System, Cryopreservation media, Embryo Culture media), Type of Cycles & End Users (Fertility Clinics and Surgical Centres, Cryobanks) - Global Forecast to 2022

Report Code: MD 4467 Oct, 2019, by marketsandmarkets.com

[181 Pages Report] MarketsandMarkets forecasts the In Vitro Fertilization market to grow from USD 465.2 million in 2016 to 847.8 million by 2022, at a Compound Annual Growth Rate (CAGR) of 10.9% during the forecast period. The major factors that are expected to be driving the IVF market are growth of this market include growth in the median age of first-time motherhood, declining fertility rates, rising male infertility, rise in consumption of alcohol and cigarettes, and growing public awareness about infertility and the available treatment options.

The objective of the report is to define, describe, and forecast the IVF market size based on type of cycle, product, end user, and region

In Vitro Fertilization Reagents Market, by Region, 2022 (USD Million)

By product, the reagents segment is expected to grow at the highest growth rate during the forecast period

By product, the in vitro fertilization market is segmented into reagents and equipment. Reagents are estimated to account for the largest share in the global market in 2017. This large share can be attributed to the fact that increasing number of IVF procedures would lead to increase in the usage of reagents

By end user, the fertility clinics and surgical centers segment to record the highest CAGR during the forecast period

On the basis of end users, the global IVF market has been segmented into fertility clinics and surgical centers, hospitals and research laboratories, and cryobanks. The fertility clinics and surgical centers segment is estimated to command the largest share of the global market in 2017. This segment is also projected to register the highest CAGR during the forecast period. The increasing number of fertility centers coupled with the growing infertility rates across the globe are the key factors driving the growth of the fertility and surgical centers segment.

In Vitro Fertilization Reagents Market, by Region, 2022 (USD Million)

Asia Pacific to account for the largest market size during the forecast period.

The APAC region is expected to hold the largest share of the global in vitro fertilization market in 2017. The region is also expected to grow at the highest growth rate during the forecast period. The large share and high growth rate of the APAC region can be attributed growth in the median age of first-time motherhood, rising infertility rates, growing prevalence of PCOS, increasing incidence of obesity, the rise in fertility tourism, and government initiatives. Europe is anticipated to be the second largest region in terms of market size in the IVF market. This can be attributed to the increasing obesity rates and PCOS in the UK, rising age of first-time pregnancy and rising obesity rates in France, declining birthrates in Germany, favorable regulatory amendments for IVF in Italy, and rise of IVF tourism in Spain.

Market Dynamics

Driver: Growth in the median age of first-time motherhood

Over the years, the median age of first-time motherhood has increased drastically across the globe. This trend can largely be attributed to improved contraceptive techniques, late marriages, and the growing number of women prioritizing their careers over starting a family. Listed below are some important statistics in this regard:

  • In the US, the rate of first-time pregnancies in women under the age of 20 decreased by 42% during 2000–2014 [Source: Centers for Disease Control and Prevention (CDC)].
  • The median age of first-time mothers in the US increased from 24.9 years in 2000 to 26.3 years in 2014 (Source: CDC).
  • According to Eurostat, in 2013, around 40.6% of women in the EU gave birth to their first baby in their 30s.
  • In France, the average age of first-time pregnancies in women has also risen over the years and was found to be higher in women in their late 20s or early 30s (Source: United Nations Department of Economics and Social Affairs' World Fertility Report).
  • In Australia, the average age of first-time mothers increased from 27.8 years in 2003 to 28.6 years in 2013 (Source: Australian Bureau of Statistics 2015).

In women, the chances of conceiving decrease after the age of 32 and by the age of 40, fertility rates drop by half. Similarly, in men, between the age of 20 to 80, the volume of semen and sperm motility (the ability of the sperm to move towards an egg) decrease continuously. Moreover, women delaying pregnancy are at a higher risk of health problems associated with pregnancy after the age of 40, including low birth weight, miscarriage, fetal abnormalities, preterm delivery, prolonged labor, and maternal morbidity.

As the median age for first-time motherhood keeps increasing, a growing number of women are expected to face difficulties in conceiving naturally. In this scenario, an increasing number of women are forced to opt for IVF treatments, which is expected to drive the growth of this market in the coming years.

Restraint: High cost and low success rate of the IVF treatment

Thousands of cycles of in vitro fertilization (IVF) are performed every year, globally. However, the high cost of IVF procedures is a major factor that limits the adoption of IVF treatment. According to the Institute for Health Policy Studies, University of California, in the US, multiple births occur after 39% of IVF cycles, whereas in Europe, the figure is 26%. The American Society for Reproductive Medicine (ASRM) lists the average price of an in vitro fertilization (IVF) cycle in the US to be USD 12,400 where the average cost of an IVF cycle with the use of fresh embryos is USD 8,158, and the median cost is USD 7,500 in the US. Moreover, the cost of the treatment drugs is also high, at an estimated USD 3,000–USD 5000 per cycle.

In addition, the probability of birth following the treatment is comparatively low. The success rate of IVF treatments is just 28% to 35%, which decreases with the age of the woman. For example, the success rate is 32.2% for women under 35, 27.7% for women aged 35 to 37, 20.8% for women aged 38 to 39, 13.6% for women aged 40 to 42, 5% for women aged 43 to 44, and 1.9% for women aged over 44 (source: BabyCenter LLC and National Health Service, UK). Owing to this, couples have to undergo multiple IVF cycles, which adds up to the overall cost of the treatment.

The cost of IVF treatment varies from country to country due to lack of reimbursement policies. Additionally, insurance companies do not generally cover the cost of infertility treatments. According to the National Infertility Association, in the US, fertility treatment is covered by only 25% of insurance plans, and many of them do not cover the expenses for the IVF treatment. In India, IVF or infertility is not considered a health issue; hence, it is not covered under general insurance. Thus, the high cost of assisted reproductive techniques to treat infertility and the lack of insurance coverage for the treatment is restraining the growth of this market.

Opportunity: Fertility tourism

Asia is one of the most preferred destinations for medical care. One of the major factors driving the medical tourism industry in Asia is the low cost for high-quality healthcare facilities delivered by doctors and surgeons trained and educated in the top institutes in the US and Europe.

According to a survey conducted by the International Federation of Fertility Societies in 2013, there are more than 600 IVF clinics across India. In addition to the availability of advanced healthcare facilities, the cost of an IVF cycle in India is around 70% lower than that of some developed countries. According to the American Society for Reproductive Medicine, an average IVF cycle in the US costs around USD 12,400, whereas the costs drop dramatically to USD 3,000 in India and USD 4,000 in Thailand. Thus, the low cost of the procedure and quality healthcare facilities in Asian countries will create growth opportunities for the IVF market.

In addition to low treatment costs, coupled with high-quality treatments, the presence of liberal laws regarding the IVF treatment is also driving fertility tourism in emerging Asian countries such as India and Thailand. For instance, Thailand is attracting couples for IVF treatment because of its liberal IVF regulations such as gender selection of the embryo before implantation, whereas IVF is banned for couples with a certain number of children in China and the IVF technology is entirely banned under all circumstances in Costa Rica. Also, clinics in India are permitted to transfer six embryos simultaneously, whereas clinics in the UK are allowed to implant two embryos.

In the European region, Spain is the preferred destination for IVF as the country has liberal laws regarding the treatment, with shorter waiting lists and higher success rates compared to other European countries.

Challenge: Reducing efficacy of infertility treatment with advancing age

The changing social scenario has resulted in an increasing number of older women seeking help from infertility clinics. As a woman ages, it takes her longer to conceive, and the chances of not being able to conceive also increase. Also, the risk of miscarriage and complications in pregnancy and childbirth increase with age.

According to the American Society for Reproductive Medicine, a 30-year-old healthy and fertile woman has about 20% chance of getting pregnant without assistance every month, whereas, for a woman aged 40 years or above, the chance decreases to 5%. Furthermore, for a woman aged 30 years, approximately 40% of the IVF cycles result in live births, whereas the success rate reduces to 20% for women older than 40. A woman aged 35 or above is 2.5 times more prone to have a miscarriage or stillbirth than a woman aged less than 35; whereas, a woman aged above 40 is more than 5 times prone to have a miscarriage or stillbirth than a woman under 35 years of age.

According to a study by the Advanced Fertility Center, Chicago, 1 in every 4 women is infertile by the age of 35. The study states that the rate of pregnancy declines gradually in the 30s and considerably declines during the late 30s and 40s. Furthermore, a research study conducted among the Hutterite women of North America, who did not use contraception, found that 11% of women were infertile by age 34, 33% by the age of 40, and 87% by the age of 45. The declining success rates of IVF treatment procedures with increasing age of patients is a major challenge for fertility treatment technologies.

Scope of the Report

Report Metric

Details

Market size available for years

2015–2022

Base year considered

2016

Forecast period

2017–2022

Forecast units

Million (USD)

Segments covered

Product (Reagents, Equipment), Type of Cycles (Fresh non-donor, Frozen non-donor, Fresh donor,  Frozen donor), End User, and Region

Geographies covered

North America, Europe, APAC, and Rest of the World

Companies covered

CooperSurgical, Inc. (US), Vitrolife AB (Sweden), Cook Medical, Inc. (US), Irvine Scientific (US), Thermo Fisher Scientific Inc. (US), EMD Sereno Inc. (US), Genea Limited (Australia), Esco Micro Pte. Ltd. (Singapore),  IVFtech ApS (Denmark), The Baker Company, Inc. (US), Kitazato Corporation (Japan), and Rocket Medical Plc. (UK

The research report categorizes the IVF to forecast the revenues and analyze the trends in each of the following sub-segments:

In Vitro Fertilization Reagents Market, by Region, 2022 (USD Million)

In Vitro Fertilization Market, By Product

  • Reagents
    • Embryo culture media
    • Cryopreservation media
    • Sperm processing media
    • Ovum processing media
  • Equipment
    • Imaging system
    • Sperm separation system
    • Cabinet
    • Ovum aspiration pump
    • Incubators
    • Micro manipulation system
    • Gas analyzer
    • Laser system
    • Accessories
    • Cryosystems
    • Anti-vibration tables
    • Witness system

In Vitro Fertilization Market, By Type of Cycles

  • Fresh non-donor
  • Frozen non-donor
  • Fresh donor
  • Frozen donor

In Vitro Fertilization Market, By End User

  • Fertility clinics  and surgical centers
  • Hospital and research laboratories
  • Cryobanks

In Vitro Fertilization Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe (RoE)
  •  APAC
    • Japan
    • China
    • India
    • RoAPAC
  • Rest of the World

Key Market Players

CooperSurgical, Inc. (US), Vitrolife AB (Sweden), Cook Medical, Inc. (US), Irvine Scientific (US), Thermo Fisher Scientific Inc. (US), EMD Sereno Inc. (US), Genea Limited (Australia), Esco Micro Pte. Ltd. (Singapore), IVFtech ApS (Denmark), The Baker Company, Inc, (US), Kitazato Corporation (Japan), Rocket Medical Plc. (UK), Hamilton Thorne, Inc. (US), Shivani Scientific (India), BIOGENICS, Inc. (US), Nidacon International AB (Sweden), Lotus Bio (Israel), Eppendorf AG (Germany), Okolab Srl (Italy), IKS International (Netherlands), Hunter Scientific (UK), Thomas Medical (US), Labotect GmbH (Germany), Shivani Scientific (India), Olympus Corporation (Japan), and RI.MOS.srl (Italy)

CooperSurgical (US) dominated the In vitro fertilization market in 2017. It has a wide product portfolio of IVF media and assisted reproductive technology. The firm offers fertility products which include lab equipment, culture media, and micro tools. These products find applications in hospitals and surgical centers, obstetricians and gynecologists, medical offices, and fertility clinics. To maintain its leading position and increase its customer base in the market, the company mainly focuses on expanding its market presence by adopting growth strategies such as acquisitions. For instance in 2016, CooperSurgical acquired Wallace Pharmaceuticals (India) to further strengthen its existing IVF product portfolio. CooperSurgical has its distribution facilities in Connecticut, Texas, and Denmark, along with diagnostic facilities located in multiple locations including California, Florida, Illinois, Michigan, New Jersey, Oregon, Texas, Canada, and the UK.

Recent Developments

  • In January 2017, Genea and Merck opened a Fertility Centre of Excellence in Bangkok.
  • In November 2016, Cooper surgical Inc. acquired Wallace Pharmaceuticals (India) to further strengthen its existing IVF product portfolio.
  • In June 2016, Esco Micro Pte. Ltd. received 510(k) certification from Food and Drug Administration (FDA) for its Miri Time-Lapse Embryo Incubator.
  • In October 2015, Irvine Scientific entered into a partnership with Biotech Inc. (US). With this partnership Irvine Scientific gained exclusive distribution rights for the CRYOLOCK vitrification device.
  • In June 2015, Merck KGaA entered into an alliance with Genea Limited (Australia) and Illumina, Inc. (US) to develop advanced assisted reproductive treatment (ART) technology.

Critical questions the report answers:

  • Where will all these developments take the industry in the long term?
  • What are the upcoming trends for the IVF market?
  • Which segment provides the most opportunity for growth?
  • Who are the leading vendors operating in this market?
  • What are the opportunities for new market entrants?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Markets Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Research Data
    2.2 Secondary Research
           2.2.1 Key Data From Secondary Sources
    2.3 Primary Research
           2.3.1 Key Insights From Primary Sources
           2.3.2 Key Industry Insights
    2.4 Market Size Estimation Methodology
    2.5 Research Design
    2.6 Market Data Validation and Triangulation
    2.7 Assumptions of the Study

3 Executive Summary (Page No. - 29)

4 Premium Insights (Page No. - 33)
    4.1 In Vitro Fertilization Market: Overview
    4.2 Market Share, By Type Of Cycle And Region (2017)
    4.3 Market, By End User, 2017 Vs. 2022
    4.4 Geographic Snapshot Of The Market

5 Market Overview (Page No. - 36)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Growth in the Median Age of First-Time Motherhood
                    5.2.1.2 Declining Fertility Rates
                    5.2.1.3 Male Infertility on the Rise
                    5.2.1.4 Rise in Consumption of Alcohol and Cigarettes
                    5.2.1.5 Growing Public Awareness About Infertility and the Available Treatment Options
                    5.2.1.6 Government Initiatives to Promote IVF Treatments
                    5.2.1.7 Introduction of New and Advanced Products
           5.2.2 Restraints
                    5.2.2.1 High Cost and Low Success Rate of the IVF Treatment
                    5.2.2.2 Restrictive Regulations and Ethical Concerns
           5.2.3 Opportunities
                    5.2.3.1 Fertility Tourism
           5.2.4 Challenges
                    5.2.4.1 Reducing Efficacy of Infertility Treatment With Advancing Age

6 In Vitro Fertilization Market, By Product (Page No. - 43)
    6.1 Introduction
    6.2 Reagents
           6.2.1 Embryo Culture Media
           6.2.2 Cryopreservation Media
           6.2.3 Sperm Processing Media
           6.2.4 OVUM Processing Media
    6.3 Equipment
           6.3.1 Imaging Systems
           6.3.2 Sperm Separation Systems
           6.3.3 Cabinets
           6.3.4 OVUM Aspiration Pumps
           6.3.5 Incubators
           6.3.6 Micromanipulator Systems
           6.3.7 Gas Analyzers
           6.3.8 Laser Systems
           6.3.9 Accessories
           6.3.10 Cryosystems
           6.3.11 Anti-Vibration Tables
           6.3.12 Witness Systems

7 In Vitro Fertilization Market, By Type of Cycle (Page No. - 64)
    7.1 Introduction
    7.2 Fresh Non-Donor IVF Cycles
    7.3 Frozen Non-Donor IVF Cycles
    7.4 Frozen Donor IVF Cycles
    7.5 Fresh Donor IVF Cycles

8 In Vitro Fertilization Market, By End User (Page No. - 71)
    8.1 Introduction
    8.2 Fertility Clinics & Surgical Centers
    8.3 Hospitals & Research Laboratories
    8.4 Cryobanks

9 In Vitro Fertilization Market, By Region (Page No. - 77)
    9.1 Introduction
    9.2 North America
           9.2.1 Regulatory Framework for IVF in the US
           9.2.2 US
                    9.2.2.1 Growth in Median Age of First-Time Motherhood
                    9.2.2.2 Declining Fertility Rates
                    9.2.2.3 Presence of Top Players Backed With Their Collaborations, Investments, and Partnerships
                    9.2.2.4 Growing Number of NGOS Providing Funding for IVF
                    9.2.2.5 Insurance Policies for IVF in the US
           9.2.3 Canada
                    9.2.3.1 Growth in First Child Bearing Age
                    9.2.3.2 Increasing Same-Sex Marriages
                    9.2.3.3 Growing Government Initiatives
    9.3 Europe
           9.3.1 Germany
                    9.3.1.1 Declining Birthrate
                    9.3.1.2 IVF Regulations
           9.3.2 UK
                    9.3.2.1 Increasing Incidence of PCOS and Obesity
                    9.3.2.2 Restrictive Reimbursement Policies
           9.3.3 France
                    9.3.3.1 Rising Age of First Time Pregnancy and Rising Obesity Rate
           9.3.4 Rest of Europe (RoE)
           9.3.5 Italy
                    9.3.5.1 Favorable Regulatory Amendments for IVF
           9.3.6 Spain
                    9.3.6.1 Rise of IVF Tourism
           9.3.7 RoE
           9.3.8 Regulatory Laws Regarding In Vitro Fertilization Market
    9.4 Asia Pacific (APAC)
           9.4.1 Japan
                    9.4.1.1 Growing Median Age in First-Time Motherhood in Japan
                    9.4.1.2 Introduction of Age Cap for Subsidized IVF Treatment
           9.4.2 China
                    9.4.2.1 Abolishment of China’s One Child Policy
           9.4.3 India
                    9.4.3.1 Increasing Prevalence of PCOS in India
                    9.4.3.2 Fertility Tourism in India
           9.4.4 Rest of Asia Pacific
                    9.4.4.1 Fertility Tourism Driving the IVF Market in Thailand
                    9.4.4.2 Rising Success Rates and Government Initiatives are Driving the Market in South Korea
                    9.4.4.3 Growing IVF Therapy Implementation Efficiency and Low Cost in Taiwan
                    9.4.4.4 Lack of Education/Awareness
                    9.4.4.5 Growing Number of Assisted Reproductive Technologies (ART) Procedures in Australia and New Zealand
    9.5 Rest of the World (RoW)
           9.5.1 Increasing Incidence of Risk Factors Causing Infertility

10 Competitive Landscape (Page No. - 132)
     10.1 Market Ranking Analysis
     10.2 Market Share Analysis

11 Company Profiles (Page No. - 134)
(Business Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments.)*
     11.1 Coopersurgical Inc. (A Subsidiary of the Cooper Companies, Inc.)
             11.1.1 Business Overview
      11.1.2 Products Offered
             11.1.3 Recent Developments
             11.1.4 MnM View
     11.2 Vitrolife AB
             11.2.1 Business Overview
      11.2.2 Products Offered
             11.2.3 Recent Developments
             11.2.4 MnM View
     11.3 Cook Medical Inc.
             11.3.1 Business Overview
      11.3.2 Products Offered
             11.3.3 Recent Developments
             11.3.4 MnM View
     11.4 Irvine Scientific
             11.4.1 Business Overview
      11.4.2 Products Offered
             11.4.3 Recent Developments
             11.4.4 MnM View
     11.5 Thermo Fisher Scientific Inc.
             11.5.1 Business Overview
      11.5.2 Products Offered
             11.5.3 Recent Developments
             11.5.4 MnM View
     11.6 EMD Sereno Inc. (Merck KGaA)
     11.7 Genea Limited
     11.8 Esco Micro Pte. Ltd.
     11.9 IVFtech APS
     11.10 The Baker Company, Inc.
     11.11 Kitazato Corporation
     11.12 Rocket Medical PLC.

*Details on Business Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key Relationships Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 173)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Introducing RT: Real-Time Market Intelligence
     12.4 Available Customizations
     12.5 Related Reports
     12.6 Author Details


List of Tables (106 Tables)

Table 1 In Vitro Fertilization Market, By Product, 2015–2022 (USD Million)
Table 2 In Vitro Fertilization Reagents Market, By Type, 2015–2022 (USD Million)
Table 3 Embryo Culture Media Market, By Country/Region, 2015–2022 (USD Million)
Table 4 Cryopreservation Media Market, By Country/Region, 2015–2022 (USD Million)
Table 5 Sperm Processing Media Market, By Country/Region, 2015–2022 (USD Million)
Table 6 OVUM Processing Media Market, By Country/Region, 2015–2022 (USD Million)
Table 7 In Vitro Fertilization Equipment Market, By Type, 2015–2022 (USD Million)
Table 8 Imaging Systems Market, By Country/Region, 2015–2022 (USD Million)
Table 9 Sperm Separation Systems Market, By Country/Region, 2015–2022 (USD Million)
Table 10 Cabinets Market, By Country/Region, 2015–2022 (USD Million)
Table 11 OVUM Aspiration Pumps Market, By Country/Region, 2015–2022 (USD Million)
Table 12 Incubators Market, By Country/Region, 2015–2022 (USD Million)
Table 13 Micromanipulator Systems Market, By Country/Region, 2015–2022 (USD Million)
Table 14 Gas Analyzers Market, By Country/Region, 2015–2022(USD Million)
Table 15 Laser Systems Market, By Country/Region, 2015–2022 (USD Million)
Table 16 Accessories Market, By Country/Region, 2015–2022 (USD Million)
Table 17 Cryosystems Market, By Country/Region, 2015–2022 (USD Million)
Table 18 Anti-Vibration Tables Market, By Country/Region, 2015–2022 (USD Million)
Table 19 Witness Systems Market, By Country/Region, 2015–2022 (USD Million)
Table 20 Comparison Between Fresh and Frozen Egg Cycles
Table 21 In Vitro Fertilization Market, By Type of Cycle, 2015–2022 (USD Million)
Table 22 Fresh Non-Donor IVF Cycles Market, By Country/Region, 2015–2022 (USD Million)
Table 23 Frozen Non-Donor IVF Cycles Market, By Country/Region, 2015–2022 (USD Million)
Table 24 Frozen Donor IVF Cycles Market, By Country/Region, 2015–2022 (USD Million)
Table 25 Fresh Donor IVF Cycles Market, By Country/Region, 2015–2022 (USD Million)
Table 26 Market, By End User, 2015–2022 (USD Million)
Table 27 Fertility Clinics & Surgical Centers Market, By Country/Region, 2015–2022 (USD Million)
Table 28 Hospitals & Research Laboratories Market, By Country/Region, 2015–2022 (USD Million)
Table 29 Cryobanks Market, By Country/Region, 2015–2022 (USD Million)
Table 30 In Vitro Fertilization Market, By Region, 2015–2022 (USD Million)
Table 31 North America: Market, By Country, 2015–2022 (USD Million)
Table 32 North America: Market, By Type of Cycle, 2015–2022 (USD Million)
Table 33 North America: Market, By Product, 2015–2022 (USD Million)
Table 34 North America: IVF Reagents Market, By Type, 2015–2022 (USD Million)
Table 35 North America: IVF Equipment Market, By Type, 2015–2022 (USD Million)
Table 36 North America: Market, By End User, 2015–2022 (USD Million)
Table 37 State Insurance Laws Related to Infertility Treatment
Table 38 US: In Vitro Fertilization Market, By Type of Cycle, 2015–2022 (USD Million)
Table 39 US: Market, By Product, 2015–2022 (USD Million)
Table 40 US: In Vitro Fertilization Reagents Market, By Type, 2015–2022 (USD Million)
Table 41 US: In Vitro Fertilization Equipment Market, By Type, 2015–2022 (USD Million)
Table 42 US: , By End User, 2015–2022 (USD Million)
Table 43 Canada: Market, By Type of Cycle, 2015–2022 (USD Million)
Table 44 Canada: Market, By Product, 2015–2017 (USD Million)
Table 45 Canada: IVF Reagents Market, By Type, 2015–2022 (USD Million)
Table 46 Canada: IVF Equipment Market, By Type, 2015–2022 (USD Million)
Table 47 Canada: Market, By End User, 2015–2022 (USD Million)
Table 48 Europe: In Vitro Fertilization Market, By Country, 2015–2022 (USD Million)
Table 49 Europe: Market, By Type of Cycle, 2015–2022 (USD Million)
Table 50 Europe: Market, By Product, 2015–2022 (USD Million)
Table 51 Europe: In Vitro Fertilization Reagents Market, By Type, 2015–2022 (USD Million)
Table 52 Europe: In Vitro Fertilization Equipment Market, By Type, 2015–2022 (USD Million)
Table 53 Europe: Market, By End User, 2015–2022 (USD Million)
Table 54 Germany: Market, By Type of Cycle, 2015–2022 (USD Million)
Table 55 Germany: Market, By Product, 2015–2022 (USD Million)
Table 56 Germany: IVF Reagents Market, By Type, 2015–2022 (USD Million)
Table 57 Germany: IVF Equipment Market, By Type, 2015–2022 (USD Million)
Table 58 Germany: Market, By End User, 2015–2022 (USD Million)
Table 59 UK: In Vitro Fertilization Market, By Type of Cycle, 2015–2022 (USD Million)
Table 60 UK: Market, By Product, 2015–2022 (USD Million)
Table 61 UK: In Vitro Fertilization Reagents Market, By Type, 2015–2022 (USD Million)
Table 62 UK: In Vitro Fertilization Equipment Market, By Type, 2015–2022 (USD Million)
Table 63 UK: Market, By End User, 2015–2022 (USD Million)
Table 64 France: Market, By Type of Cycle, 2015–2022 (USD Million)
Table 65 France: Market, By Product, 2015–2022 (USD Million)
Table 66 France: IVF Reagents Market, By Type, 2015–2022 (USD Million)
Table 67 France: IVF Equipment Market, By Type, 2015–2022 (USD Million)
Table 68 France: Market, By End User, 2015–2022 (USD Million)
Table 69 Average Cost of IVF Treatment in Spain (2016)
Table 70 Regulatory Laws Regarding IVF in Rest of Europe
Table 71 RoE: In Vitro Fertilization Market, By Type of Cycle, 2015–2022 (USD Million)
Table 72 RoE: Market, By Product, 2015–2022 (USD Million)
Table 73 RoE: In Vitro Fertilization Reagents Market, By Type, 2015–2022 (USD Million)
Table 74 RoE: In Vitro Fertilization Equipment Market, By Type, 2015–2022 (USD Million)
Table 75 RoE: Market, By End User, 2015–2022 (USD Million)
Table 76 Asia Pacific: Market, By Region, 2015–2022 (USD Million)
Table 77 Asia Pacific: Market, By Type of Cycle, 2015–2022 (USD Million)
Table 78 Asia Pacific: Market, By Product, 2015–2022 (USD Million)
Table 79 Asia Pacific: IVF Reagents Market, By Type, 2015–2022 (USD Million)
Table 80 Asia Pacific: IVF Equipment Market, By Type, 2015–2022 (USD Million)
Table 81 Asia Pacific: Market, By End User, 2015–2022 (USD Million)
Table 82 Japan: In Vitro Fertilization Market, By Type of Cycle, 2015–2022 (USD Million)
Table 83 Japan: Market, By Product, 2015–2022 (USD Million)
Table 84 Japan: In Vitro Fertilization Reagents Market, By Type, 2015–2022 (USD Million)
Table 85 Japan: In Vitro Fertilization Equipment Market, By Type, 2015–2022 (USD Million)
Table 86 Japan: Market, By End User, 2015–2022 (USD Million)
Table 87 China: In Vitro Fertilization Market, By Type of Cycle, 2015–2022 (USD Million)
Table 88 China: Market, By Product, 2015–2022 (USD Million)
Table 89 China: IVF Reagents Market, By Type, 2015–2022 (USD Million)
Table 90 China: IVF Equipment Market, By Type, 2015–2022 (USD Million)
Table 91 China: Market, By End User, 2015–2022 (USD Million)
Table 92 India: Market, By Type of Cycle, 2015–2022 (USD Million)
Table 93 India: Market, By Product, 2015–2022 (USD Million)
Table 94 India: In Vitro Fertilization Reagents Market, By Type, 2015–2022 (USD Million)
Table 95 India: In Vitro Fertilization Equipment Market, By Type, 2015–2022 (USD Million)
Table 96 India: Market, By End User, 2015–2022 (USD Million)
Table 97 RoAPAC: In Vitro Fertilization Market, By Type of Cycle, 2015–2022 (USD Million)
Table 98 RoAPAC: Market, By Product, 2015–2022 (USD Million)
Table 99 RoAPAC: IVF Reagents Market, By Type, 2015–2022 (USD Million)
Table 100 RoAPAC: IVF Equipment Market, By Type, 2015–2022 (USD Million)
Table 101 RoAPAC: Market, By End User, 2015–2022 (USD Million)
Table 102 RoW: In Vitro Fertilization Market, By Type of Cycle, 2015–2022 (USD Million)
Table 103 RoW: Market, By Product, 2015–2022 (USD Million)
Table 104 RoW: In Vitro Fertilization Reagents Market, By Type, 2015–2022 (USD Million)
Table 105 RoW: In Vitro Fertilization Equipment Market, By Type, 2015–2022 (USD Million)
Table 106 RoW: Market, By End User, 2015–2022 (USD Million)


List of Figures (33 Figures)

Figure 1 Research Methodology: Global In Vitro Fertilization Market
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Sampling Frame: Primary Research
Figure 4 Key Data From Primary Sources
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 Global In Vitro Fertilization Market, By End Users, 2017
Figure 9 Global Market, By Types of Cycles, 2017 vs 2022 (USD Million)
Figure 10 Global Market, By Product, 2017 vs 2022 (USD Million)
Figure 11 Global In Vitro Fertilization Reagents Market, By Type, 2017 vs 2022 (USD Million)
Figure 12 Global In Vitro Fertilization Equipment Market, By Type, 2017 vs 2022 (USD Million)
Figure 13 Geographical Snapshot of the In Vitro Fertilization Market
Figure 14 Delayed Pregnancy in Women is A Major Factor Driving the Growth of the IVF Market
Figure 15 The Fresh Nondonor Cycle is Expected to Account for the Largest Share of the Market in 2017
Figure 16 Fertility Clinics and Surgical Centres to Continue to Dominate the global Market in 2022
Figure 17 Asia Pacific to Register the Highest CAGR in the Forecast Period
Figure 18 In Vitro Fertilization Market: Drivers, Restraints, Opportunities, & Challenges
Figure 19 Reagents to Account for the Largest Share of the Market in 2017, 2017 V/S 2022 (USD Million)
Figure 20 Embryo Culture Media to Account for the Largest Share of the global Market in 2017, 2017 V/S 2022 (USD Million)
Figure 21 Imaging Systems to Account for the Largest Share of the In Vitro Fertilization Market in 2017, 2017 V/S 2022 (USD Million)
Figure 22 Fresh Non-Donor IVF Cycles Segment to Account for the Largest Share of the global Market in 2017, 2017 V/S 2022 (USD Million)
Figure 23 Fertility Clinics & Surgical Centers to Account for the Largest Share of the Market in 2017, 2017 V/S 2022 (USD Million)
Figure 24 In Vitro Fertilization Market, By Region, 2017 vs 2022 (USD Million)
Figure 25 North America: Market Snapshot
Figure 26 Europe: Market Snapshot
Figure 27 Asia Pacific Market Snapshot
Figure 28 Rest of the World (RoW) Market Snapshot
Figure 29 Global In Vitro Fertilization Market Ranking, By Key Player, 2016
Figure 30 Global Market Share Analysis, By Key Player (2016)
Figure 31 Coopersurgical Inc.: Company Snapshot (2016)
Figure 32 Vitrolife AB: Company Snapshot (2016)
Figure 33 Thermo Fisher Scientific Inc.: Company Snapshot (2016)


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 4467
Published ON
Oct, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the In Vitro Fertilization Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home